Seeking A Better Treatment For Idiopathic Pulmonary Fibrosis: FibroGen's Pamrevlumab And Prometic's PBI-4050 Seeking Alpha, 15 Aug 2017 Summary IPF is a debilitating and fatal lung disease with no cure, having a median survival of 3 years.